Orlando M Gutiérrez Selected Research

Dietary Phosphorus

11/2013	The connection between dietary phosphorus, cardiovascular disease, and mortality: where we stand and what we need to know.
1/2013	Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.
3/2011	Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey.
2/2011	Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease.
7/2010	Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Orlando M Gutiérrez Research Topics

Disease

39	Chronic Renal Insufficiency 01/2022 - 08/2008
24	Stroke (Strokes) 01/2020 - 10/2012
21	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 11/2010
15	Kidney Diseases (Kidney Disease) 10/2022 - 08/2008
7	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 06/2011
7	Inflammation (Inflammations) 01/2022 - 07/2011
6	Renal Insufficiency (Renal Failure) 10/2022 - 09/2010
6	Hypertension (High Blood Pressure) 01/2022 - 09/2013
6	Coronary Disease (Coronary Heart Disease) 01/2020 - 08/2013
6	Heart Failure 01/2019 - 01/2016
5	Anemia 09/2021 - 04/2010
5	Sepsis (Septicemia) 01/2020 - 04/2015
4	Albuminuria 01/2020 - 07/2011
4	Obesity 01/2019 - 01/2015
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2016 - 05/2009
4	Hyperphosphatemia 12/2011 - 08/2008
3	Cognitive Dysfunction 01/2020 - 10/2014
3	Vascular Diseases (Vascular Disease) 01/2020 - 05/2011
3	Insulin Resistance 09/2016 - 01/2015
3	Vitamin D Deficiency 09/2016 - 07/2011
3	Secondary Hyperparathyroidism 09/2012 - 09/2010
2	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 12/2021 - 12/2017
2	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 09/2021 - 01/2020
2	Iron Deficiencies 09/2021 - 01/2020
2	Infections 12/2018 - 09/2015
2	Atherosclerosis 01/2018 - 09/2012
2	Myocardial Infarction 09/2015 - 09/2013
2	Hyperparathyroidism 12/2011 - 04/2011
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Bone Diseases (Bone Disease) 12/2021
1	Oncogenic osteomalacia 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Meningioma (Meningiomas) 01/2020
1	Pain (Aches) 01/2020
1	Hypophosphatemia 01/2020
1	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019

Drug/Important Bio-Agent (IBA)

24	Fibroblast Growth Factor-23IBA 10/2021 - 08/2008
18	AlbuminsIBA 01/2022 - 07/2011
17	CreatinineIBA 01/2022 - 07/2011
16	Phosphates (Orthophosphate)IBA 01/2022 - 08/2008
16	Phosphorus (Red Phosphorus)IBA 12/2021 - 08/2008
10	MineralsIBA 12/2021 - 12/2010
10	Parathyroid Hormone (Parathormone)IBA 10/2021 - 09/2010
9	Vitamin D FDA LinkGeneric 10/2021 - 04/2010
9	25-hydroxyvitamin DIBA 11/2019 - 04/2010
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2008
8	hydroxide ionIBA 10/2021 - 09/2013
7	Antihypertensive Agents (Antihypertensives)IBA 10/2021 - 12/2011
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 09/2013
6	Hemoglobins (Hemoglobin)IBA 01/2020 - 04/2010
6	C-Reactive ProteinIBA 01/2020 - 01/2015
5	Cystatin CIBA 01/2022 - 04/2015
5	Hormones (Hormone)IBA 01/2016 - 08/2008
5	Dietary PhosphorusIBA 11/2013 - 07/2010
4	IronIBA 09/2021 - 01/2016
4	pro-brain natriuretic peptide (1-76)IBA 01/2019 - 06/2014
3	LipidsIBA 01/2022 - 05/2015
3	Apolipoprotein L1IBA 01/2022 - 05/2015
3	Interleukin-6 (Interleukin 6)IBA 05/2018 - 07/2011
3	Calcitriol (Calcijex)FDA LinkGeneric 01/2018 - 07/2011
3	1,25-dihydroxyvitamin DIBA 09/2010 - 08/2008
2	insulin receptor-related receptor (IRR)IBA 01/2020 - 01/2020
2	Natriuretic PeptidesIBA 01/2019 - 01/2018
2	Interleukin-10 (Interleukin 10)IBA 05/2018 - 01/2015
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 06/2014
2	AdiponectinIBA 09/2016 - 01/2015
2	ResistinIBA 09/2016 - 01/2015
2	CalciumIBA 04/2016 - 04/2011
2	LDL CholesterolIBA 05/2015 - 06/2014
2	DiureticsIBA 05/2014 - 04/2011
1	trimethyloxamine (trimethylamine N-oxide)IBA 10/2022
1	symmetric dimethylarginineIBA 10/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	calcium phosphateIBA 10/2021
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	CholesterolIBA 09/2021
1	burosumabIBA 01/2020
1	ferrous sulfate FDA Link 01/2020
1	ferric citrateIBA 01/2020
1	N 30IBA 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Ferritins (Ferritin)IBA 01/2020
1	Transferrin (beta 2 Transferrin)IBA 01/2020
1	OsteocalcinIBA 01/2020
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020
1	LeptinIBA 01/2020
1	OsteopontinIBA 01/2020
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	Serum AlbuminIBA 10/2018
1	Fibrinogen (Factor I)FDA Link 05/2018

Therapy/Procedure

9	Therapeutics 10/2022 - 02/2009
1	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2021
1	Diet Therapy (Therapy, Diet) 12/2018